Skip to content
tilman_schoening2_bw

Seminar Title

 

Seminar N2: Targeted medicines in hospital pharmacy: one problem – two views?

Affiliation

Heidelberg University Hospital

Country

Germany

1. Current Status, Position

Dr Schöning is Deputy Head of Pharmacy.

2. Education

  • Licensure as Pharmacist in 2000;
  • 2000-present: University Hospital of Heidelberg, Pharmacy;
  • Head of Oncology Pharmacy Unit together with central preparation unit of cytotoxic drugs;
  • Pharmaceutical management of clinical studies phase I-III in accordance to GCP and GMP;
  • Quality management representative;
  • Lecturer of clinical pharmacy at the School of Pharmacy, University of Heidelberg;
  • Lecturer of pharmacology at the School of Nursing;
  • Since 2004: Specialist in Hospital Pharmacy (“Klinische Pharmazie”, PharmD);
  • PhD (Dr. sc. hum.), 2009, University of Heidelberg. Thesis: “Antimicrobial susceptibility of clinical Group-B-streptococci isolates and molecular typing of resistant strains from two different german regions”;
  • Chair of Oncology Board of the German Association of Hospital Pharmacists (ADKA)
  • Vice President of the German Association of Oncology Pharmacy (DGOP)

3. Research Area

Dr Schöning is engaged in various fields of Oncology Pharmacy.

Conflict of interest: Past consultant for various pharma companies.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.